Itzhak Mendel

508 total citations
23 papers, 431 citations indexed

About

Itzhak Mendel is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Itzhak Mendel has authored 23 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Itzhak Mendel's work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Itzhak Mendel is often cited by papers focused on Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Itzhak Mendel collaborates with scholars based in Israel, United States and United Kingdom. Itzhak Mendel's co-authors include Avraham Ben‐Nun, Nicole Kerlero de Rosbo, Ethan M. Shevach, Niva Yacov, Eyal Breitbart, Dror Harats, Erez Feige, Jacob George, Itzhak Levi and Abel François and has published in prestigious journals such as The Journal of Immunology, Cancer Research and International Journal of Cancer.

In The Last Decade

Itzhak Mendel

23 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itzhak Mendel Israel 13 259 116 80 36 35 23 431
Duncan R. McKenzie Australia 11 375 1.4× 70 0.6× 124 1.6× 31 0.9× 56 1.6× 14 511
Sankaranarayana P. Mahesh United States 15 211 0.8× 81 0.7× 62 0.8× 72 2.0× 37 1.1× 32 639
Lisa K. Kozicky Canada 11 191 0.7× 132 1.1× 34 0.4× 22 0.6× 26 0.7× 13 434
Claire Wynne Ireland 10 325 1.3× 183 1.6× 60 0.8× 34 0.9× 52 1.5× 15 509
Marianna Boncristiano Italy 10 345 1.3× 152 1.3× 69 0.9× 33 0.9× 43 1.2× 12 601
Shweta Jain United States 13 298 1.2× 113 1.0× 67 0.8× 27 0.8× 55 1.6× 21 461
Krisztina Kerekes Hungary 14 273 1.1× 206 1.8× 29 0.4× 21 0.6× 28 0.8× 30 510
Weiwei Ma China 11 451 1.7× 122 1.1× 124 1.6× 20 0.6× 35 1.0× 25 651

Countries citing papers authored by Itzhak Mendel

Since Specialization
Citations

This map shows the geographic impact of Itzhak Mendel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itzhak Mendel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itzhak Mendel more than expected).

Fields of papers citing papers by Itzhak Mendel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itzhak Mendel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itzhak Mendel. The network helps show where Itzhak Mendel may publish in the future.

Co-authorship network of co-authors of Itzhak Mendel

This figure shows the co-authorship network connecting the top 25 collaborators of Itzhak Mendel. A scholar is included among the top collaborators of Itzhak Mendel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itzhak Mendel. Itzhak Mendel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yacov, Niva, Arnon Karni, Nitsan Maharshak, et al.. (2025). MOSPD2 regulates the activation state of αLβ2 integrin to control monocyte migration: applicability for treatment of chronic inflammatory diseases. Immunologic Research. 73(1). 78–78. 1 indexed citations
2.
Yacov, Niva, et al.. (2020). MOSPD2 is a therapeutic target for the treatment of CNS inflammation. Clinical & Experimental Immunology. 201(2). 105–120. 10 indexed citations
3.
Shapira‐Frommer, Ronnie, Iris Barshack, Itzhak Mendel, et al.. (2019). Abstract 4979: Ofranergene Obadenovec (VB-111), an anti-cancer gene therapy, induces immunologic responses in solid tumors transforming cold tumors to hot tumors. Cancer Research. 79(13_Supplement). 4979–4979. 1 indexed citations
4.
Brenner, Andrew, Katherine B. Peters, James J. Vredenburgh, et al.. (2019). Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study. Neuro-Oncology. 22(5). 694–704. 32 indexed citations
5.
Yacov, Niva, et al.. (2018). Newly characterized motile sperm domain‐containing protein 2 promotes human breast cancer metastasis. International Journal of Cancer. 144(1). 125–135. 7 indexed citations
6.
Mendel, Itzhak, et al.. (2017). Identification of Motile Sperm Domain–Containing Protein 2 as Regulator of Human Monocyte Migration. The Journal of Immunology. 198(5). 2125–2132. 12 indexed citations
7.
Mendel, Itzhak, et al.. (2016). Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. Digestive Diseases and Sciences. 61(9). 2545–2553. 15 indexed citations
8.
Mendel, Itzhak, Niva Yacov, Dror Harats, & Eyal Breitbart. (2014). Therapies Targeting Innate Immunity for Fighting Inflammation in Atherosclerosis. Current Pharmaceutical Design. 21(9). 1185–1195. 13 indexed citations
9.
Feige, Erez, Niva Yacov, Itzhak Levi, et al.. (2013). Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE−/− mice. Atherosclerosis. 229(2). 430–439. 16 indexed citations
10.
Mendel, Itzhak, Erez Feige, Niva Yacov, et al.. (2013). VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clinical & Experimental Immunology. 175(1). 126–137. 28 indexed citations
11.
Mendel, Itzhak, et al.. (2010). A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease. Journal of Neuroimmunology. 226(1-2). 126–135. 13 indexed citations
12.
Feige, Erez, Itzhak Mendel, Jacob George, Niva Yacov, & Dror Harats. (2010). Modified phospholipids as anti-inflammatory compounds. Current Opinion in Lipidology. 21(6). 525–529. 29 indexed citations
13.
Peled, Michael, Aviv Shaish, Shoshana Greenberger, et al.. (2008). Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect. Cancer Gene Therapy. 15(8). 535–542. 7 indexed citations
14.
Mendel, Itzhak & Ethan M. Shevach. (2005). Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology. 117(2). 196–204. 36 indexed citations
15.
16.
Mendel, Itzhak & Ethan M. Shevach. (2002). The IL-10-producing competence of Th2 cells generated in vitro is IL-4 dependent. European Journal of Immunology. 32(11). 3216–3224. 25 indexed citations
17.
Mendel, Itzhak & Ethan M. Shevach. (2002). Differentiated Th1 autoreactive effector cells can induce experimental autoimmune encephalomyelitis in the absence of IL-12 and CD40/CD40L interactions. Journal of Neuroimmunology. 122(1-2). 65–73. 12 indexed citations
18.
Étienne, Isabelle, Abel François, M Redonnet, et al.. (2000). Does polyomavirus infection induce renal failure in cardiac transplant recipients?. Transplantation Proceedings. 32(8). 2794–2795. 22 indexed citations
19.
Ben‐Nun, Avraham, Itzhak Mendel, & Nicole Kerlero de Rosbo. (1997). Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.. PubMed. 109(2). 120–5. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duncan R. McKenzie Breakdown of academic impact, for papers by Sankaranarayana P. Mahesh Breakdown of academic impact, for papers by Lisa K. Kozicky Breakdown of academic impact, for papers by Claire Wynne Breakdown of academic impact, for papers by Marianna Boncristiano Breakdown of academic impact, for papers by Shweta Jain Breakdown of academic impact, for papers by Krisztina Kerekes Breakdown of academic impact, for papers by Weiwei Ma
Rankless by CCL
2026